170 related articles for article (PubMed ID: 25544659)
1. Efficacy of vaccination against HPV infection to prevent cervical cancer in France.
Ribassin-Majed L; Hill C; Lounes R
Public Health; 2015 Jan; 129(1):78-81. PubMed ID: 25544659
[No Abstract] [Full Text] [Related]
2. [Cervical HPV infection; epidemiology and vaccination].
Yoshikawa H
Kansenshogaku Zasshi; 2008 Nov; 82(6):609-12. PubMed ID: 19086414
[No Abstract] [Full Text] [Related]
3. Efficacy of vaccination against HPV infections to prevent cervical cancer in France: present assessment and pathways to improve vaccination policies.
Ribassin-Majed L; Lounes R; Clémençon S
PLoS One; 2012; 7(3):e32251. PubMed ID: 22427828
[TBL] [Abstract][Full Text] [Related]
4. HPV vaccination: unanswered questions remain.
Linhares IM; Witkin SS
BJOG; 2015 Jan; 122(1):118. PubMed ID: 25208474
[No Abstract] [Full Text] [Related]
5. [Cervical carcinoma and the vaccination experience with Cervarix].
Berberova M
Akush Ginekol (Sofiia); 2012; 51 Suppl 1():4-5. PubMed ID: 23236670
[No Abstract] [Full Text] [Related]
6. Vaccination against human papillomavirus types 16 and 18: the impact on cervical cancer.
Berkhof J; Bogaards JA
Future Oncol; 2010 Dec; 6(12):1817-21. PubMed ID: 21142854
[No Abstract] [Full Text] [Related]
7. [Cervical cancer: vaccination against cancer. Updates on vaccination and early detection].
Deutsches Grünes Kreuz e.V
Kinderkrankenschwester; 2015 Dec; 34(12):458. PubMed ID: 26946633
[No Abstract] [Full Text] [Related]
8. Issues in human papillomavirus vaccination in adolescents.
Moscicki AB; Smith JS
J Adolesc Health; 2008 Oct; 43(4 Suppl):S1-4. PubMed ID: 18809142
[No Abstract] [Full Text] [Related]
9. [Cervix carcinoma--Austrian Vaccination Committee recommends HPV vaccination].
Six L; Joura EA
Wien Med Wochenschr; 2007; 157(5-6):130-2. PubMed ID: 17427010
[No Abstract] [Full Text] [Related]
10. Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial.
Apter D; Wheeler CM; Paavonen J; Castellsagué X; Garland SM; Skinner SR; Naud P; Salmerón J; Chow SN; Kitchener HC; Teixeira JC; Jaisamrarn U; Limson G; Szarewski A; Romanowski B; Aoki FY; Schwarz TF; Poppe WA; Bosch FX; Mindel A; de Sutter P; Hardt K; Zahaf T; Descamps D; Struyf F; Lehtinen M; Dubin G;
Clin Vaccine Immunol; 2015 Apr; 22(4):361-73. PubMed ID: 25651922
[TBL] [Abstract][Full Text] [Related]
11. HPV single-dose vaccination: Impact potential, evidence base and further evaluation.
Stanley M; Dull P
Vaccine; 2018 Aug; 36(32 Pt A):4759-4760. PubMed ID: 29754700
[No Abstract] [Full Text] [Related]
12. [Vaccination against HPV in adults].
Gil Á
Rev Esp Quimioter; 2009 Nov; 22 Suppl 1():22-5. PubMed ID: 20084345
[No Abstract] [Full Text] [Related]
13. [Implementation of HPV vaccination in Germany].
Schreckenberger C; Kaufmann AM; Schneider A
Dtsch Med Wochenschr; 2007 Oct; 132(42):2221-4. PubMed ID: 17926251
[No Abstract] [Full Text] [Related]
14. Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine: final analysis of a long-term follow-up study up to 9.4 years post-vaccination.
Naud PS; Roteli-Martins CM; De Carvalho NS; Teixeira JC; de Borba PC; Sanchez N; Zahaf T; Catteau G; Geeraerts B; Descamps D
Hum Vaccin Immunother; 2014; 10(8):2147-62. PubMed ID: 25424918
[TBL] [Abstract][Full Text] [Related]
15. AS04-adjuvanted human papillomavirus-16/18 vaccination: recent advances in cervical cancer prevention.
Schwarz TF
Expert Rev Vaccines; 2008 Dec; 7(10):1465-73. PubMed ID: 19053203
[TBL] [Abstract][Full Text] [Related]
16. [Vaccination perspective against human papillomavirus and consequences for the screening of uterine cervical neoplasm].
Delvenne P
Bull Mem Acad R Med Belg; 2007; 162(10-12):483-8; discussion 489-90. PubMed ID: 18557390
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus vaccine efficacy: aligning expectations with reality.
Smith-McCune KK
Gynecol Oncol; 2008 Oct; 111(1):1-2. PubMed ID: 18922296
[No Abstract] [Full Text] [Related]
18. Who should be targeted for vaccination against anal cancer?
Harper DM; Vierthaler SL
Lancet Oncol; 2011 Sep; 12(9):828-9. PubMed ID: 21865086
[No Abstract] [Full Text] [Related]
19. [Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany].
Schneider A; Schwarz TF; Hammerschmidt T; Siebert U
Med Klin (Munich); 2007 Jul; 102(7):515-23. PubMed ID: 17634869
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseases.
Skinner SR; Apter D; De Carvalho N; Harper DM; Konno R; Paavonen J; Romanowski B; Roteli-Martins C; Burlet N; Mihalyi A; Struyf F
Expert Rev Vaccines; 2016; 15(3):367-87. PubMed ID: 26902666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
